Skip to main content

EBGLYSS (lebrikizumab)

Australian Public Assessment Report
Device/Product Name
EBGLYSS
Active ingredients
Lebrikizumab
AusPAR Date
Published
Submission Number
PM-2023-01192-1-1
Submission Type
New biological entity
Decision
Approved

Help us improve the Therapeutic Goods Administration site